Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Country / region: Poland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20063
20071
20111
20131
20161
20171
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
Amgen1
Eli Lilly and Company1
Gilead Sciences1
GlaxoSmithKline1
Hoffmann-La Roche1
Incyte Corporation1
NCIC Clinical Trials Group1
NantCell, Inc.1
OSI Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms13
Adenocarcinoma2
Endocrine Gland Neoplasms2
Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Pancreatic Ductal1
Colorectal Neoplasms1
Digestive System Diseases1
Digestive System Neoplasms1
Endocrine System Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.